Premarket Approval (PMA) | 合法醫療器材資訊網

2021年6月28日 — The FDA first approved Senseonics' 90-day Eversense sensor in June 2018, but the new version, which aims to double its lifespan, has been ... Read More

2020年12月29日 — Senseonics' plans to roll out its new, long-term diabetes sensor implant will be pushed to the middle of next year as FDA reviewers continue to ... Read More

2020年2月26日 — Senseonics Announces the FDA Approval to Continue the PROMISE Sensor Clinical Study in an Extended Cohort to 365 Days to Gather ... Read More

2020年10月5日 — Senseonics Submits PMA Application for 180-Day Eversense System to the FDA ... GERMANTOWN, Md. --(BUSINESS WIRE)-- Senseonics ... Read More

FDA對於Senseonics植入式連續血糖儀Eversense系統審查延宕2個月2021年中才有望獲得批准. 日期: 2021/1/4 作者: 蔡雪綸(生技投資第一站) 疫情效應 、 血糖 、 ... Read More

30th.2020 last year, and it is NOW total 9 months since it was applied to FDA, in which $SENS CEO and Top management ... Read More

5 天前 — !(imminent). As most of existing investors are well aware, FDA applications of FDA180-DAY CGM XL has been submitted since ... Read More

Super Search Devices@FDA 6 ... Senseonics, Incorporated. 20451 seneca meadows parkway. germantown, MD 20876-7005 ... Read More

2021年6月4日 — Eversense, which is considered a direct competitor to DexCom's CGM systems, first won a nod from FDA in 2018. Senseonics filed to get ... Read More